Fibromyalgia (FM) is associated with adverse cardiometabolic profiles and reduced quality of life. Although plant-based dietary patterns have shown cardiovascular benefits, their effects in FM remain unclear. This randomized, parallel-arm controlled trial evaluated the effect of a vegan Mediterranean diet (VegMedDiet) compared with a traditional Mediterranean diet (MedDiet) on low-density lipoprotein cholesterol (LDL-C) and FM-related outcomes. Twenty-two women with FM were assigned to follow either a VegMedDiet (n = 11) or a MedDiet (n = 11) for 6 weeks. Diets were isocaloric and matched for macronutrient distribution. The primary outcome was change in LDL-C; secondary outcomes included other cardiometabolic markers, body composition, and FM-related symptoms and were considered exploratory. Outcomes were analyzed using linear mixed-effects models accounting for repeated measures. Compared with the MedDiet, the VegMedDiet produced greater reductions in LDL-C (estimated mean difference -21.2 mg/dL; 95% CI: -38.3 to -4.08) and triglycerides (-27.4 mg/dL; 95% CI: -52.1 to -2.73). Additionally, a significantly greater reduction was observed in the FIQ pain item (estimated mean difference -1.88; 95% CI: -2.99 to -0.77; P = 0.002). These findings suggest that a VegMedDiet may contribute to short-term improvements in cardiometabolic risk markers and FM-related symptoms compared with a MedDiet, supporting its potential role as a dietary strategy in individuals with FM.
Plant-based dietary interventions have emerged as promising strategies for fibromyalgia (FM), although their effectiveness may depend on participants’ adherence to the prescribed dietary pattern. This secondary analysis of the FIBROVEG randomized controlled trial investigated dietary adherence, its determinants, and its association with clinical response in women with FM. Twenty-two participants were randomly assigned to follow either a vegan Mediterranean diet or a traditional Mediterranean diet for six weeks (ClinicalTrials.gov: NCT06804460). Adherence was assessed using a predefined food-group-based score, while diet satisfaction and perceived barriers were evaluated using validated questionnaires. Adherence was moderate to high in both groups but was greater in the vegan Mediterranean diet group than in the traditional Mediterranean diet group (86.4 ± 11.3% vs. 72.7 ± 11.9%). In the vegan Mediterranean diet group, lower adherence was associated with a busy lifestyle, time required for meal preparation, and unfamiliar foods. Higher adherence was correlated with greater reductions in low-density lipoprotein cholesterol, neutrophil-to-lymphocyte ratio, and fatigue, whereas no clear associations were observed in the traditional Mediterranean diet group. These findings suggest that a vegan Mediterranean diet is feasible in the short term under structured conditions in women with FM and that greater adherence may contribute to more favorable cardiometabolic and fatigue-related outcomes.